JPRN-jRCT2080221737未知3 期
A Phase III Clinical Trial of Duloxetine in Participants With Fibromyalgia
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •Participants fulfilling the criteria in the American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. And et al.
排除标准
- •Participants with past history of multiple episodes of drug allergy.
- •Participants previously treated with duloxetine.
研究者
相似试验
未知
3 期
A phase 3 clinical trial of duloxetine in patients with osteoarthritisosteoarthritisJPRN-jRCT2080222625Shionogi & Co., Ltd.
未知
3 期
A phase 3 clinical trial of duloxetine in patients with chronic low back paiChronic low back painJPRN-jRCT2080222083SHIONOGI & CO., LTD.
未知
4 期
A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic PaiDiabetic Peripheral Neuropathic PainJPRN-jRCT1080222824Shionogi & Co., Ltd.
已完成
3 期
A phase 3 clinical trial of duloxetine in children and adolescents with depressive disorderJPRN-jRCT2080223678Shionogi & Co., Ltd.149
已完成
不适用
effect of Duloxetine in treatment of ADHDAttention Deficit Hyperactivity Disorder(ADHD).Attention deficit: disorder with hyperactivity hyperactivity disorder syndrome with hyperactivityIRCT2012072210363N1niversity of Social Welfare and Rehabilitation Sciences10